Antonio Oliver
#146,526
Most Influential Person Now
Researcher
Antonio Oliver's AcademicInfluence.com Rankings
Antonio Olivercomputer-science Degrees
Computer Science
#7389
World Rank
#7780
Historical Rank
Computational Linguistics
#1465
World Rank
#1481
Historical Rank
Machine Learning
#2707
World Rank
#2742
Historical Rank
Artificial Intelligence
#3002
World Rank
#3048
Historical Rank
Download Badge
Computer Science
Antonio Oliver's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Antonio Oliver Influential?
(Suggest an Edit or Addition)Antonio Oliver's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. (2000) (1501)
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study (2020) (1402)
- ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. (2015) (563)
- The increasing threat of Pseudomonas aeruginosa high-risk clones. (2015) (434)
- Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. (2008) (413)
- Antimicrobial susceptibility testing in biofilm-growing bacteria. (2014) (353)
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. (2017) (347)
- Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. (2010) (343)
- Hypermutation Is a Key Factor in Development of Multiple-Antimicrobial Resistance in Pseudomonas aeruginosa Strains Causing Chronic Lung Infections (2005) (301)
- Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections (2019) (284)
- Coevolution with viruses drives the evolution of bacterial mutation rates (2007) (277)
- The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants (2002) (262)
- Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation (2008) (246)
- Antibiotic treatment of biofilm infections (2017) (238)
- β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein (2009) (236)
- Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. (2008) (236)
- Characterization of Clinical Isolates ofKlebsiella pneumoniae from 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended-Spectrum β-Lactamase Detection Methods (2001) (230)
- Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 (2021) (229)
- Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital (Madrid, 1989 to 2000) (2002) (211)
- Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. (2000) (208)
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals (2007) (200)
- Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones (2012) (192)
- OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumanniiClinical Strain (2000) (190)
- OXA-24, a Novel Class D β-Lactamase with Carbapenemase Activity in an Acinetobacter baumannii Clinical Strain (2006) (188)
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC (2014) (187)
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study (2011) (186)
- Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. (2010) (181)
- Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues (2006) (168)
- Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction in Pseudomonas aeruginosa Clinical Strains (2005) (163)
- Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. (2005) (161)
- Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. (2009) (159)
- Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development (2006) (155)
- Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates (2015) (152)
- Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period (2002) (152)
- Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. (2011) (152)
- Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections (2004) (150)
- Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli (2010) (148)
- Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities (2012) (135)
- Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. (2015) (134)
- Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa (2018) (133)
- Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort. (2013) (133)
- Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections (2011) (128)
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
- Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection. (2009) (124)
- The Versatile Mutational Resistome of Pseudomonas aeruginosa (2018) (124)
- Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and Meropenem (2015) (124)
- Nucleotide Sequence and Characterization of a Novel Cefotaxime-Hydrolyzing β-Lactamase (CTX-M-10) Isolated in Spain (2001) (114)
- Alterations of OprD in Carbapenem-Intermediate and -Susceptible Strains of Pseudomonas aeruginosa Isolated from Patients with Bacteremia in a Spanish Multicenter Study (2012) (111)
- Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients (2010) (107)
- PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa (2006) (106)
- Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. (2010) (106)
- Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain (2017) (106)
- Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2013) (105)
- Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections. (2017) (104)
- Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain (2009) (102)
- Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. (2007) (98)
- Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones (2013) (97)
- Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone (2017) (96)
- Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals (2011) (95)
- Nontuberculous mycobacteria in patients with cystic fibrosis. (2001) (92)
- Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa (2010) (91)
- Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. (2018) (90)
- Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains (2009) (89)
- Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coli (2002) (88)
- Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics (2019) (88)
- Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. (2008) (87)
- Benefit of Having Multiple ampD Genes for Acquiring β-Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa (2008) (86)
- Evaluation of the NCCLS Extended-Spectrum β-Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE (2003) (86)
- Pseudomonas aeruginosa RsmA Plays an Important Role during Murine Infection by Influencing Colonization, Virulence, Persistence, and Pulmonary Inflammation (2007) (85)
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae. (2016) (85)
- Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants (2009) (85)
- Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. (2010) (84)
- CTX-M-10 Linked to a Phage-Related Element Is Widely Disseminated among Enterobacteriaceae in a Spanish Hospital (2005) (83)
- Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing (2016) (82)
- Efficacy and Potential for Resistance Selection of Antipseudomonal Treatments in a Mouse Model of Lung Infection by Hypermutable Pseudomonas aeruginosa (2006) (81)
- WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent “β-Lactam Enhancer” Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones (2017) (80)
- Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. (2010) (80)
- VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain (2012) (78)
- Characterization of the New Metallo-β-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain (2008) (78)
- Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. (2020) (74)
- Structure and interaction with phospholipids of a prokaryotic lipoxygenase from Pseudomonas aeruginosa (2013) (72)
- Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology. (2019) (71)
- Inappropriate use of antibiotics in hospitals: the complex relationship between antibiotic use and antimicrobial resistance. (2013) (70)
- Detection and Susceptibility Testing of Hypermutable Pseudomonas aeruginosa Strains with the Etest and Disk Diffusion (2004) (69)
- Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance? (2002) (69)
- Two Mechanisms of Killing of Pseudomonas aeruginosa by Tobramycin Assessed at Multiple Inocula via Mechanism-Based Modeling (2015) (68)
- [Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]. (2012) (67)
- Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection (2013) (66)
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain. (2016) (65)
- Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy (2018) (64)
- Lack of Association between Hypermutation and Antibiotic Resistance Development in Pseudomonas aeruginosa Isolates from Intensive Care Unit Patients (2004) (64)
- Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections. (2012) (63)
- Environmental Microbiota Represents a Natural Reservoir for Dissemination of Clinically Relevant Metallo-β-Lactamases (2011) (62)
- Inactivation of the Glycoside Hydrolase NagZ Attenuates Antipseudomonal β-Lactam Resistance in Pseudomonas aeruginosa (2009) (62)
- Role of Pseudomonas aeruginosa Low-Molecular-Mass Penicillin-Binding Proteins in AmpC Expression, β-Lactam Resistance, and Peptidoglycan Structure (2015) (60)
- Antagonistic Interactions of Pseudomonas aeruginosa Antibiotic Resistance Mechanisms in Planktonic but Not Biofilm Growth (2011) (60)
- Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm Treatment (2011) (59)
- Evolution and Adaptation in Pseudomonas aeruginosa Biofilms Driven by Mismatch Repair System-Deficient Mutators (2011) (58)
- High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms (2012) (58)
- A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition (2011) (58)
- Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. (2017) (58)
- NagZ Inactivation Prevents and Reverts β-Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa (2010) (56)
- In Vivo Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa (2017) (54)
- Transferable Multidrug Resistance Plasmid Carrying cfr Associated with tet(L), ant(4′)-Ia, and dfrK Genes from a Clinical Methicillin-Resistant Staphylococcus aureus ST125 Strain (2012) (54)
- Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates (2017) (54)
- Novel phosphorylcholine-containing protein of Pseudomonas aeruginosa chronic infection isolates interacts with airway epithelial cells. (2008) (54)
- Inactivation of the Mismatch Repair System in Pseudomonas aeruginosa Attenuates Virulence but Favors Persistence of Oropharyngeal Colonization in Cystic Fibrosis Mice (2007) (54)
- Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway. (2011) (54)
- Molecular Characterization of FOX-4, a New AmpC-Type Plasmid-Mediated β-Lactamase from an Escherichia coli Strain Isolated in Spain (2000) (53)
- ampG Gene of Pseudomonas aeruginosa and Its Role in β-Lactamase Expression (2010) (53)
- AmpG Inactivation Restores Susceptibility of Pan-β-Lactam-Resistant Pseudomonas aeruginosa Clinical Strains (2011) (50)
- Determining &bgr;-lactam exposure threshold to suppress resistance development in Gram-negative bacteria (2017) (50)
- Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. (2013) (49)
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli (2012) (49)
- Corrigendum to Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2 [Int. J. Antimicrob. Agents 34 (2009) 173-176] (2010) (49)
- Characterization of the GO system of Pseudomonas aeruginosa. (2002) (49)
- Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
- Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. (2012) (49)
- Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. (2005) (48)
- Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands (2018) (47)
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
- Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway? (2016) (45)
- The problems of antibiotic resistance in cystic fibrosis and solutions (2015) (45)
- A trade-off between oxidative stress resistance and DNA repair plays a role in the evolution of elevated mutation rates in bacteria (2013) (44)
- Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms (2016) (43)
- The Pseudomonas aeruginosa CreBC Two-Component System Plays a Major Role in the Response to β-Lactams, Fitness, Biofilm Growth, and Global Regulation (2014) (43)
- Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. (2007) (43)
- Comparative Evaluation of the Automated Roche TaqMan Real-Time Quantitative Human Immunodeficiency Virus Type 1 RNA PCR Assay and the Roche AMPLICOR Version 1.5 Conventional PCR Assay (2007) (42)
- Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1. (2010) (42)
- Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia (2019) (41)
- Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae (2018) (41)
- Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections (2010) (41)
- Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care (2021) (40)
- In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens (2020) (40)
- THE EFFECT OF ELEVATED MUTATION RATES ON THE EVOLUTION OF COOPERATION AND VIRULENCE OF PSEUDOMONAS AERUGINOSA (2010) (40)
- Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants (2019) (38)
- Influence of High Mutation Rates on the Mechanisms and Dynamics of In Vitro and In Vivo Resistance Development to Single or Combined Antipseudomonal Agents (2007) (37)
- Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting (2018) (36)
- Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients (2012) (35)
- In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure. (2015) (35)
- Identifying and exploiting genes that potentiate the evolution of antibiotic resistance (2018) (35)
- Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1 ß-Lactamase (2009) (35)
- Differential beta-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains. (2010) (35)
- Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. (2009) (34)
- Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams. (2013) (33)
- A Standard Numbering Scheme for Class C β-Lactamases (2019) (33)
- Ampicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different β-Lactam Resistance Phenotypes (1999) (32)
- Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. (2018) (32)
- Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. (2015) (32)
- Evaluation of the Panbio rapid antigen test for SARS-CoV-2 in primary health care centers and test sites. (2020) (31)
- Detection of the Novel Extended-Spectrum β-Lactamase OXA-161 from a Plasmid-Located Integron in Pseudomonas aeruginosa Clinical Isolates from Spain (2009) (30)
- Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegansPseudomonas aeruginosa Infection Model (2017) (30)
- Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
- First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa. (2013) (29)
- Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection (2021) (29)
- Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system (2017) (28)
- Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. (2014) (28)
- Evolution of Pseudomonas aeruginosa pathogenicity: from acute to chronic infections. (2008) (27)
- Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies. (2016) (27)
- Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens (2018) (27)
- Nontypable Haemophilus influenzae Displays a Prevalent Surface Structure Molecular Pattern in Clinical Isolates (2011) (27)
- Deciphering &bgr;-lactamase-independent &bgr;-lactam resistance evolution trajectories in Pseudomonas aeruginosa (2018) (26)
- Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains (2015) (26)
- Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases. (2010) (26)
- Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15. (2007) (25)
- Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections. (2020) (24)
- Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa. (2016) (24)
- Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain. (2013) (24)
- Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management. (2012) (24)
- First Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn2006 in Spain (2012) (24)
- Overexpression of MexCD-OprJ Reduces Pseudomonas aeruginosa Virulence by Increasing Its Susceptibility to Complement-Mediated Killing (2014) (23)
- Characterization of a novel Zn²⁺-dependent intrinsic imipenemase from Pseudomonas aeruginosa. (2014) (23)
- Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections (2016) (23)
- Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study. (2019) (23)
- Activity of the new cephalosporin CXA‐101 (FR264205) against Pseudomonas aeruginosa isolates from chronically‐infected cystic fibrosis patients (2010) (23)
- Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania (2016) (22)
- Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam (2019) (22)
- In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae (2019) (22)
- Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study. (2016) (22)
- Social Behavior of Antibiotic Resistant Mutants Within Pseudomonas aeruginosa Biofilm Communities (2019) (22)
- Performance of the VITEK2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates. (2001) (22)
- Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC‐2: A Step against Bacterial Resistance (2018) (21)
- Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection. (2020) (21)
- Synergistic activity of fosfomycin, &bgr;-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa (2017) (21)
- Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model (2018) (21)
- Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study. (2013) (21)
- Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling (2019) (21)
- Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model (2018) (21)
- Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study. (2017) (21)
- [Carbapenemases in Pseudomonas spp]. (2010) (21)
- Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. (2010) (20)
- Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. (2001) (20)
- Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients (2018) (20)
- Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis. (2021) (19)
- Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone (2019) (19)
- Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital. (2012) (19)
- The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant (2021) (19)
- [Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]. (2012) (19)
- Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam (2020) (18)
- Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates (2014) (18)
- Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients. (2015) (18)
- Development of antibiotic resistance and up-regulation of the antimutator gene pfpI in mutator Pseudomonas aeruginosa due to inactivation of two DNA oxidative repair genes (mutY, mutM). (2011) (18)
- Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC β-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in Spain (2015) (17)
- High beta-Lactamase Levels Change the Pharmacodynamics of beta-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms Levels (2012) (17)
- Epidemiological relatedness of methicillin-resistant Staphylococcus aureus from a tertiary hospital and a geriatric institution in Spain. (2004) (17)
- Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. (2022) (17)
- Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection. (2012) (17)
- Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients (2018) (17)
- Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa. (2020) (17)
- Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis (2018) (16)
- O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones (2019) (16)
- N-Acetylcysteine Selectively Antagonizes the Activity of Imipenem in Pseudomonas aeruginosa by an OprD-Mediated Mechanism (2015) (16)
- Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli. (2016) (16)
- Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study (2017) (16)
- Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones. (2019) (16)
- TEM-71, a Novel Plasmid-Encoded, Extended-Spectrum β-Lactamase Produced by a Clinical Isolate of Klebsiella pneumoniae (2002) (15)
- Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved? (2014) (15)
- Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms (2017) (15)
- Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study. (2020) (15)
- In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa. (2020) (15)
- Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases—authors' response (2011) (14)
- [The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA]. (2014) (14)
- 1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa (2018) (14)
- Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey. (2019) (14)
- Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp (2014) (14)
- Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high risk-clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2. (2020) (14)
- Epidemiological and Clinical Complexity of Amoxicillin-Clavulanate-Resistant Escherichia coli (2013) (13)
- Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance. (2017) (13)
- Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump (2021) (13)
- Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain. (2015) (12)
- Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain. (2017) (12)
- Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices (2014) (12)
- Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients (2015) (12)
- Chronic Respiratory Infections by Mucoid Carbapenemase-Producing Pseudomonas aeruginosa Strains, a New Potential Public Health Problem (2008) (12)
- Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone (2013) (12)
- Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones (2019) (11)
- Characterization of a Novel IMP-28 Metallo-β-Lactamase from a Spanish Klebsiella oxytoca Clinical Isolate (2012) (11)
- Rapid Detection of Pseudomonas aeruginosa Biofilms via Enzymatic Liquefaction of Respiratory Samples. (2020) (11)
- Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. (2021) (11)
- In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections (2021) (11)
- Microbiological methods for surveillance of carrier status of multiresistant bacteria. (2017) (10)
- [Nosocomial spread of linezolid-resistant Staphylococcus hominis in two hospitals in Majorca]. (2011) (10)
- A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates (2020) (10)
- Prevalence of extended‐spectrum β‐lactamases in group‐1 β‐lactamase‐producing isolates (2001) (10)
- Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections (2021) (10)
- In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection. (2021) (10)
- Understanding the acute inflammatory response to Pseudomonas aeruginosa infection: differences between susceptible and multidrug-resistant strains in a mouse peritonitis model. (2017) (9)
- Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections (2019) (9)
- Hypermutation in natural bacterial populations: consequences for medical microbiology (2005) (9)
- Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy. (2020) (9)
- Long-term Persistence of an Extensively Drug Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center. (2019) (9)
- [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis]. (2009) (9)
- Erratum for del Barrio-Tofiño et al., “Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain” (2017) (8)
- Pseudomonas aeruginosa: a clinical and genomics update. (2021) (8)
- Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins (2019) (8)
- Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane (2022) (8)
- Nosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa (2020) (8)
- In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity. (2019) (8)
- Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274) (2020) (8)
- Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
- Increased Susceptibility to Colistin in Hypermutable Pseudomonas aeruginosa Strains from Chronic Respiratory Infections (2007) (8)
- Surfactant Protein A Recognizes Outer Membrane Protein OprH on Pseudomonas aeruginosa Isolates From Individuals With Chronic Infection. (2016) (7)
- Characterization of the New AmpC β-Lactamase FOX-8 Reveals a Single Mutation, Phe313Leu, Located in the R2 Loop That Affects Ceftazidime Hydrolysis (2013) (7)
- Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates (2021) (7)
- Emergence of Resistance to Novel β-Lactam–β-Lactamase Inhibitor Combinations Due to Horizontally Acquired AmpC (FOX-4) in Pseudomonas aeruginosa Sequence Type 308 (2019) (7)
- Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS. (2020) (7)
- Antimicrobial stewardship programs: a public health priority in Spain. The SEIMC-REIPI initiative. (2013) (7)
- From CLSI to EUCAST, a necessary step in Spanish laboratories. (2018) (7)
- Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model (2020) (7)
- Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission (2021) (7)
- [Molecular characterization of a glycopeptide-resistant Enterococcus faecalis outbreak in an intensive care unit]. (2005) (6)
- Antimicrobial stewardship in Spain: Programs for Optimizing the use of Antibiotics (PROA) in Spanish hospitals. (2018) (6)
- 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics. (2021) (6)
- Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections. (2020) (6)
- In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy. (2021) (6)
- Recommendations for antibiotic selection for severe nosocomial infections (2021) (6)
- Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model (2019) (6)
- Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems. (2020) (6)
- Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain (2014) (5)
- Bedside Detection of Carbapenemase-Producing Pathogens with Plasmonic Nanosensors (2020) (5)
- [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)]. (2008) (5)
- Mobile origami immunosensors for the rapid detection of urinary tract infections. (2020) (5)
- Immunodetection of Lung IgG and IgM Antibodies against SARS-CoV-2 via Enzymatic Liquefaction of Respiratory Samples from COVID-19 Patients. (2021) (5)
- Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis. (2017) (5)
- Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model (2021) (5)
- Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections (2022) (5)
- [Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. (2007) (5)
- In Vivo Selection of Moxifloxacin-Resistant Clostridium difficile (2012) (5)
- Epidemiology and carbapenem resistance mechanisms in Pseudomonas aeruginosa: Role of high-risk clones in multidrug resistance. (2017) (5)
- Metagenomics Analysis Reveals an Extraordinary Inner Bacterial Diversity in Anisakids (Nematoda: Anisakidae) L3 Larvae (2020) (4)
- Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study. (2020) (4)
- Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis (2021) (4)
- Draft Genome Sequence of the Quorum-Sensing and Biofilm-Producing Pseudomonas aeruginosa Strain Pae221, Belonging to the Epidemic High-Risk Clone Sequence Type 274 (2015) (4)
- Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP. (2022) (4)
- Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (4)
- Microbiological methods for surveillance of carrier status of multiresistant bacteria (2017) (4)
- Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model (2020) (4)
- Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial (2022) (4)
- Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient (2022) (4)
- Molecular Basis of AmpC β-Lactamase Induction by Avibactam in Pseudomonas aeruginosa: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants (2021) (4)
- Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii (2019) (4)
- Prevalence of extended-spectrum beta-lactamases in group-1 beta-lactamase-producing isolates. (2001) (4)
- Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling (2019) (3)
- Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. (2022) (3)
- Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study (2022) (3)
- in Cystic Fibrosis Lung Infection aeruginosa Pseudomonas High Frequency of Hypermutable (2009) (3)
- In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa (2022) (3)
- Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model. (2021) (3)
- Hemithioindigo‐Based Visible Light‐Activated Molecular Machines Kill Bacteria by Oxidative Damage (2022) (3)
- Genetic and Kinetic Characterization of the Novel AmpC β-Lactamases DHA-6 and DHA-7 (2014) (3)
- Impacto de la diseminación de Pseudomonas aeruginosa multirresistente productora de metalo-β-lactamasas en los hospitales: presente y futuro (2009) (3)
- Emergence of high level and stable metronidazole resistance in Clostridioides difficile. (2019) (3)
- Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria. (2022) (2)
- CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3 (2022) (2)
- Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa (2022) (2)
- Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients. (2022) (2)
- A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections? (2021) (2)
- Clinical relevance of Pseudomonas aeruginosa hypermutation in cystic fibrosis chronic respiratory infection. (2015) (2)
- Activity of mammalian peptidoglycan-targeting immunity against Pseudomonas aeruginosa. (2020) (2)
- Pan-β-lactam Resistance Development in Pseudomonas aeruginosa 1 Clinical Strains : Molecular Mechanisms , PBPs Profiles and Binding 2 Affinities (2012) (2)
- Polyclonal pathogen populations accelerate the evolution of antibiotic resistance in patients (2021) (2)
- Pseudomonas aeruginosa producing the extended-spectrum β- (2009) (2)
- Challenging antimicrobial susceptibility and evolution of resistance (OXA-681) during treatment of a Pseudomonas aeruginosa ST175 clone long-term nosocomial infection. (2019) (2)
- Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone (2017) (2)
- VIM-47, a New Variant of the Autochthonous Metallo-β-Lactamase VIM-13 from the Balearic Islands in Spain (2016) (2)
- Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software (2022) (2)
- Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis (2022) (2)
- Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial. (2022) (2)
- Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds (2022) (2)
- Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram‐negatives (2022) (2)
- Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study. (2021) (2)
- The first wave of the Spanish COVID-19 epidemic was associated with early introductions and fast spread of a dominating genetic variant (2020) (2)
- Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence (2022) (2)
- In vitro and in vivo efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogens (2019) (1)
- Deciphering the resistome of the widespread P. aeruginosa ST175 international high-risk clone through whole genome sequencing (2018) (1)
- [Carbapenem resistance and Acinetobacter baumannii]. (2004) (1)
- [Nosocomial pneumonia due to community-acquired, methicillin-resistant, Panton-Valentine-leukocidin-producing Staphylococcus aureus]. (2008) (1)
- Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies) (2022) (1)
- [Consolidation of a Staphylococcus aureus multiresistant clone not related to the Iberian in a hospital from Mallorca]. (2005) (1)
- Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates (2022) (1)
- [Comparison of the microdilution method (PASCO), the Etest and disc-diffusion in streptococcus pneumoniae antibiotic susceptibility testing]. (1998) (1)
- Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence (2022) (1)
- Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not to high-risk clones. (2022) (1)
- Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins (2019) (1)
- [Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future]. (2009) (1)
- PSEUDOMONAS AERUGINOSA PATHOGENICITY WITHIN CLONAL STRAINS FROM PATIENTS WITH CYSTIC FIBROSIS (2008) (1)
- Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands (2018) (1)
- Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa 1 (2011) (1)
- Comparison of Local Features from Two Spanish Hospitals Reveals Common and Specific Traits at Multiple Levels of the Molecular Epidemiology of Metallo-β-Lactamase-Producing Pseudomonas spp (2014) (1)
- Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. (2022) (1)
- ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa (2022) (1)
- Draft Genome Sequences of Four Pseudomonas aeruginosa Isolates Obtained from Patients with Chronic Obstructive Pulmonary Disease (2017) (1)
- In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies). (2022) (1)
- Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling (2022) (1)
- Identifying and exploiting genes that potentiate the evolution of antibiotic resistance (2018) (1)
- Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections. (2023) (0)
- Whole Genome Sequencing Evidences High Rates of Relapse in Clostridioides difficile Infection Caused by the Epidemic Ribotype 106 (2023) (0)
- Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices (2014) (0)
- Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. (2022) (0)
- From CLSI to EUCAST, a necessary step in Spanish laboratories (2020) (0)
- Monzón Spain Strain Isolated in Escherichia coli from an-Lactamase β AmpC-Type Plasmid-Mediated Molecular Characterization of FOX-4 , a New (2000) (0)
- Engaging Community Pharmacies in detection of missing Tuberculosis patients through Public- Private Mix intervention in Pakistan (2019) (0)
- [Microbiological diagnosis of bacterial lower respiratory tract infections]. (2008) (0)
- Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients (2012) (0)
- O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones (2019) (0)
- Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains (2015) (0)
- Benefit of Having Multiple ampD Genes for Acquiring (cid:2) -Lactam Resistance without Losing Fitness and Virulence in Pseudomonas aeruginosa (cid:1) (2008) (0)
- Corrigendum to ``Emergence of high level and stable metronidazole resistance in Clostridioides difficile'' [International Journal of Antimicrobial Agents Vol. 55 (2020) 5830]. (2020) (0)
- Pharmacokinetic/Pharmacodynamic (PK/PD) Model of Pseudomonas (2011) (0)
- Erratum for Pincus et al., “A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates” (2021) (0)
- Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa (2022) (0)
- Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy (2020) (0)
- NagZ Inactivation Prevents and Reverts (cid:1) -Lactam Resistance, Driven by AmpD and PBP 4 Mutations, in Pseudomonas aeruginosa (cid:1) (2010) (0)
- 89 Hypermutation in Burkholderia cepacia complex is highly prevalent in chronic respiratory infections of cystic fibrosis patients (2014) (0)
- Assessing the contribution of gut-to-lung translocation to bacterial colonization and antibiotic resistance in an ICU patient (2022) (0)
- PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability (2022) (0)
- Evaluation of Roche Cobas Taqman Quantitative HIV-1 RNA PCR against other HIV-1 commercial viral load tests to examine potential under-quantification (2008) (0)
- Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania (2015) (0)
- Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop. (2018) (0)
- Nontypable Haemophilus influenzae surface structure molecular pattern and associated virulence phenotypes in unrelated and serial clinical isolates (2011) (0)
- Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential (2023) (0)
- Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital. (2023) (0)
- 60 Ceftazidime shows concentration-dependent killing on ß-lactamase-overproducing biofilm of Pseudomonas aeruginosa (2012) (0)
- Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins (2020) (0)
- Rapid evolution drives the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection (2020) (0)
- panish Consensus on the Prevention and Treatment of Pseudomonas eruginosa Bronchial Infections in Cystic Fibrosis Patients (2018) (0)
- Whole-genome sequence-guided PCR for the rapid identification of thePseudomonas aeruginosa ST175 high-risk clone directly from clinical samples. (2020) (0)
- Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (0)
- Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae (2023) (0)
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals (cid:1) (2007) (0)
- 83 Bronchopulmonary infection/colonization in cystic fibrosis: results from a Spanish multicenter study (2014) (0)
- Killing effect of R-pyocins on susceptible and multiresistant Pseudomonas aeruginosa clinical isolates (2016) (0)
- Visible‐Light‐Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload (2023) (0)
- Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa (cid:1) (2010) (0)
- Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion. (2022) (0)
- P1349 Risk factors for ciprofioxacin resistance among ESBL-producing Escherichia coli isolated from non-hospitalised patients in Spain (2007) (0)
- Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa (2023) (0)
- Evaluation of the biological cost of Pseudomonas aeruginosa hypermutation in a murine model of chronic pulmonary infection (2005) (0)
- The CreBCD System is Involved in One-Step High Level β-lactam Resistance Development in Pseudomonas aeruginosa (2008) (0)
- A Standard Numbering Scheme for Class C (cid:2) -Lactamases (2021) (0)
- Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports. (2022) (0)
- O296 EF-Tu, a novel phosphorylcholine-containing protein involved in the interaction of chronic infectious Pseudomonas aeruginosa isolates with the airway epithelial cells (2007) (0)
- Lung pathogenesis of Pseudomonas aeruginosa hypermutable strains from patients with cystic fibrosis (2008) (0)
- Whole genome sequencing evidences higher rates of relapse in Clostridioides difficile infection caused by PCR ribotype 106 (2021) (0)
- Erratum to: Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain (2012) (0)
- Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) (0)
- P1652 Susceptibility of extended-spectrum β-lactamase-producing Escherichia coli strains causing nosocomially- and community-acquired bacteraemia (2007) (0)
- P880 Single-step selection of double mutations leading to high antibiotic-resistance in hyper-mutable Pseudomonas aeruginosa (2007) (0)
- [Molecular analysis of an outbreak of Serratia marcescens and its possible connection with the use of a chlorhexidine solution]. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Antonio Oliver?
Antonio Oliver is affiliated with the following schools:
